Jinping Xie

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Technical and regulatory challenges in cell therapy products: lessons from unsuccessful IND and BLA/NDA approvals.

Technical and regulatory challenges in cell therapy products: lessons from unsuccessful IND and BLA/NDA approvals.

Journal: Cell death discovery

Published: April 20, 2026

Spatial accessibility and equity analysis of designated medical insurance pharmacies in China.

Spatial accessibility and equity analysis of designated medical insurance pharmacies in China.

Journal: BMC health services research

Published: February 10, 2026

Clinical value and cost-effectiveness analysis of conditionally approved anticancer drugs in China from 2015 to 2023.

Clinical value and cost-effectiveness analysis of conditionally approved anticancer drugs in China from 2015 to 2023.

Journal: Translational cancer research

Published: January 05, 2026

Trends and an age-period-cohort analysis of testicular cancer incidence and mortality in China from 1990 to 2021.

Trends and an age-period-cohort analysis of testicular cancer incidence and mortality in China from 1990 to 2021.

Journal: Cancer epidemiology

Published: July 21, 2024

Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective.

Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective.

Journal: BMC public health

Published: June 14, 2024

The Impact of Regulatory Reforms in China on Drug Lag: The Role of Clinical Development Strategies.

The Impact of Regulatory Reforms in China on Drug Lag: The Role of Clinical Development Strategies.

Journal: Clinical pharmacology and therapeutics

Published: September 27, 2023

Comparison of novel oncology drugs that received dual approval from the US accelerated approval and EU conditional marketing authorisation pathways, 2006-2021: a cross-sectional study.

Comparison of novel oncology drugs that received dual approval from the US accelerated approval and EU conditional marketing authorisation pathways, 2006-2021: a cross-sectional study.

Journal: BMJ open

Published: June 07, 2023

Progress and Challenges of the New Conditional Approval Process in China: A Pooled Analysis From 2018 to 2021.

Progress and Challenges of the New Conditional Approval Process in China: A Pooled Analysis From 2018 to 2021.

Journal: Clinical therapeutics

Published: February 05, 2023

Correlates of residents' enrolment intention toward inclusive commercial health insurance in China: involvement, perceived benefit, perceived sacrifice, and government participation.

Correlates of residents' enrolment intention toward inclusive commercial health insurance in China: involvement, perceived benefit, perceived sacrifice, and government participation.

Journal: Frontiers in public health

Published: December 12, 2022

Female perspective: the burden of Alzheimer's disease and other dementias in China from 1990 to 2019 and prediction of their prevalence up to 2044.

Female perspective: the burden of Alzheimer's disease and other dementias in China from 1990 to 2019 and prediction of their prevalence up to 2044.

Journal: Frontiers in public health

Published: November 22, 2022

Factors associated with delayed diagnosis of Crohn's disease: A systematic review and meta-analysis.

Factors associated with delayed diagnosis of Crohn's disease: A systematic review and meta-analysis.

Journal: Heliyon

Published: October 20, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026